GBS Inc. GBS
0.47 0.00 (+0.00%)
At closeOct 27, 2022, 12:00 AM EDT
0.4507 Day range 0.4854
52-week range unavailable
News
gurufocus.com Intuit (INTU) Reports Strong Q4 but Cautious FY27 Guidance Raises Concerns Intuit (INTU) shares are down despite a robust Q4 earnings report and a 15% increase in dividends. Investors are concerned about the softer-than-expected guidan
gurufocus.com Hansa Biopharma announces first commercial kidney transplant patient treated with Idefirix in Australia Hansa Biopharma announces first commercial kidney transplant patient treated with Idefirix in Australia PR Newswire
gurufocus.com Hansa Biopharma reports positive efficacy and safety results from Idefirix® European post authorization study in kidney transplantation Hansa Biopharma reports positive efficacy and safety results from Idefirix European post authorization study in kidney transplantation
gurufocus.com Hansa Biopharma Announces Late-Breaking Abstract from ConfIdeS Phase 3 Trial Selected for Oral Presentation at ATC 2026 Hansa Biopharma Announces Late-Breaking Abstract from ConfIdeS Phase 3 Trial Selected for Oral Presentation at ATC 2026 PR News
gurufocus.com Is Intuit (INTU) Undervalued After Q3 FY26 Earnings? EPS $11.09 Beats Estimates, Revenue $8.56B Misses; GF Score 87/100, 51.2% Undervalued Filing date: May 20, 2026GAAP diluted EPS was $11.09, which is higher than the estimated EPS of $10.65.Revenue was $8,558 million, which is below the estimated
gurufocus.com Hansa Biopharma enters into €115 million licensing agreement with SERB Pharmaceuticals for IDEFIRIX in Europe and MENA Hansa Biopharma enters into â¬115 million licensing agreement with SERB Pharmaceuticals for IDEFIRIX in Europe and MENA PR New
globenewswire.com 110 Years. 110 Stories. 110 Reasons to Raise Awareness for GBS CONSHOHOCKEN, Pa., May 11, 2026 (GLOBE NEWSWIRE) -- May is GBS|CIDP Awareness Month and this year marks 110 years since the discovery of Guillain-Barré syndrome (GBS), which was first identified and…
gurufocus.com Larry Robbins Increases Stake in DXC Technology Co Transaction Overview On March 20, 2026, Larry Robbins (Trades, Portfolio), through Glenview Capital Management, increased the firm's stake in DXC Technology Co
prnewswire.com Kimberly-Clark Appoints Francesco Tinto as Chief Information & GBS Officer DALLAS, March 6, 2026 /PRNewswire/ -- Kimberly-Clark Corporation (NASDAQ: KMB) today announced the appointment of Francesco Tinto as Chief Information & Global Business Services (GBS) Officer,…
globenewswire.com Annexon Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barré Syndrome (GBS) at 2025 Peripheral Nerve Society (PNS) Annual Meeting First Oral Presentation of the Tanruprubart Real-World Evidence (RWE) Study by International Guillain-Barré Syndrome Outcomes Study (IGOS) Researchers Highlights Benefits over Current Standard of…
globenewswire.com Annexon Announces Presentations on the Clinical Advancement of Tanruprubart as the First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) at the 2025 PNS Meeting First Oral Presentation by the International Guillain-Barré Syndrome Outcomes Study (IGOS) of the Real-World Evidence (RWE) Results Showing Improved Outcomes with Tanruprubart (formerly ANX005)…
globenewswire.com Annexon Highlights Pivotal Data on First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) and Showcases New GBS Education Campaign at American Academy of Neurology (AAN) 2025 Annual Meeting Oral Presentation Features Phase 3 Data Showing Rapid Recovery and Durable Benefit of Tanruprubart (formerly ANX005) on Clinically Meaningful Measures across Multiple Stages of GBS
globenewswire.com Annexon Highlights Leadership in Advancing Clinical Research and Education for Guillain-Barré Syndrome (GBS) at American Academy of Neurology (AAN) 2025 Annual Meeting Oral Plenary Presentation on Tuesday, April 8 Features Phase 3 Data for ANX005, the First Potential Targeted Therapy for GBS, Showing Rapid and Durable Benefit Across Clinical Measures and Time Points
prnewswire.com Hansa Biopharma announces positive full results from 15-HMedIdeS-09 Phase 2 study and comparative analysis of imlifidase in patients with Guillain-Barré Syndrome LUND, Sweden , Dec. 17, 2024 /PRNewswire/ -- Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA), today announced positive full results from the 15-HMedIdeS-09 single arm Phase 2 study of imlifidase, a…
globenewswire.com Annexon Announces Positive Topline Results from Real-World Evidence Study Comparing ANX005 Treatment to Intravenous Immunoglobulin (IVIg) or Plasma Exchange (PE) in a Matched Patient Cohort for the Treatment of Guillain-Barré Syndrome (GBS) Real-World Evidence Study Strengthens the Body of Evidence Supporting ANX005 for Treatment of GBS ANX005 Phase 3 Population Was Matched 1:1 on Prespecified Criteria with Patients in International GBS…
seekingalpha.com GBS, Inc. (GBS) Q4 2022 Earnings Call Transcript GBS, Inc. (NASDAQ:GBS ) Q4 2022 Earnings Conference Call August 31, 2022 4:30 PM ET Company Participants Steven Boyages - Chairman and Interim CEO Spiro Sakiris - CFO Conference Call Participants…
benzinga.com Earnings Scheduled For August 31, 2022 Companies Reporting Before The Bell • Hywin Holdings (NASDAQ:HYW) is expected to report earnings for its fourth quarter.
globenewswire.com GBS Inc. to Present Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Update on August 31 Company to Host Conference Call & Webcast at 4:30 p.m. ET Company to Host Conference Call & Webcast at 4:30 p.m. ET
globenewswire.com GBS Inc. to Present at the H.C. Wainwright Global Investment Conference NEW YORK, May 16, 2022 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at…
seekingalpha.com GBS Inc.'s (GBS) CEO Dr. Steven Boyages on Q3 2022 Results - Earnings Call Transcript GBS Inc. (NASDAQ:GBS ) Q3 2022 Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants Dr. Steven Boyages - Chairman and Interim CEO Spiro Sakiris - Chief Financial Officer Conference…
benzinga.com Earnings Scheduled For May 10, 2022 Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.
globenewswire.com GBS Inc. to Present Third Quarter 2022 Financial Results and Recent Corporate Update on May 10 Company to Host Conference Call & Webcast at 4:30 p.m. ET Company to Host Conference Call & Webcast at 4:30 p.m. ET
benzinga.com 88 Biggest Movers From Yesterday Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) climbed 203.3% to settle at $1.00 on Tuesday. Hycroft recently reported preliminary FY21 operating results.
benzinga.com 28 Stocks Moving in Wednesday's Pre-Market Session Gainers Guardion Health Sciences, Inc. (NASDAQ: GHSI) rose 46.4% to $0.4098 in pre-market trading after jumping around 48% on Tuesday. Guardion Health Sciences recently reported closing of $11…- benzinga.com 80 Biggest Movers From Yesterday Gainers
benzinga.com 36 Stocks Moving In Tuesday's Mid-Day Session Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) climbed 193% to $0.9962 after jumping 36% on Monday.- benzinga.com 27 Stocks Moving in Tuesday's Pre-Market Session Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) rose 123.4% to $0.76 in pre-market trading after jumping 36% on Monday.
benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 348 companies hit new 52-week lows.
benzinga.com 60 Biggest Movers From Yesterday Gainers Inspirato Incorporated (NASDAQ: ISPO) shares climbed 618.2% to close at $92.65 on Thursday, just a few days after the company completed its SPAC merger with Thayer Ventures.- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 115 companies reached new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday During Monday's session, 291 companies made new 52-week lows. Also check out this: Insiders Buying These 4 Penny Stocks
benzinga.com 52 Weeks High And Low Article On Friday, 106 companies reached new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 89 companies hit new 52-week lows.
- benzinga.com Earnings Scheduled For February 10, 2022 Companies Reporting Before The Bell • Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million.
benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 105 stocks hit new 52-week lows.- benzinga.com Earnings Scheduled For November 11, 2021 Companies Reporting Before The Bell • NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million.
- benzinga.com 54 Biggest Movers From Yesterday Gainers Focus Universal Inc. (NASDAQ: FCUV) shares climbed 278% to close at $19.28 on Wednesday. The stock started trading on Nasdaq Capital Market yesterday.
- benzinga.com Earnings Scheduled For August 11, 2021 Companies Reporting Before The Bell • Wireless Telecom Group (AMEX:WTT) is likely to report earnings for its second quarter.
- benzinga.com 54 Biggest Movers From Yesterday Gainers Sight Sciences, Inc. (NASDAQ: SGHT) shares jumped 39.6% to settle at $33.50 on Thursday as the company priced its IPO at $24 per share.
- benzinga.com 32 Stocks Moving In Thursday's Mid-Day Session Gainers ATA Creativity Global (NASDAQ: AACG) shares jumped 37.8% to $4.1050.
- benzinga.com 55 Biggest Movers From Yesterday Gainers Moving iMage Technologies, Inc. (NYSE: MITQ) shares jumped 700% to settle at $24.00 on Thursday. Moving iMage Technologies priced its initial public offering of 4.2 million common shares at…
- benzinga.com 62 Biggest Movers From Yesterday Gainers
- benzinga.com 75 Biggest Movers From Yesterday Gainers Clover Health Investments, Corp. (NASDAQ: CLOV) shares surged 85.8% to close at $22.15 on Tuesday amid increased retail investor interest in the stock.
- benzinga.com 64 Biggest Movers From Yesterday Gainers
- benzinga.com 52 Biggest Movers From Yesterday Gainers Regional Health Properties, Inc. (NYSE: RHE) shares climbed 102.5% to close at $14.62 on Monday after jumping 38% on Friday.
benzinga.com 84 Biggest Movers From Yesterday Gainers AeroCentury Corp. (NYSE: ACY) shares climbed 414.9% to close at $13.85 on Monday after the company reported that the NYSE accepted its plan for continued listing.- benzinga.com 58 Stocks Moving In Monday's Mid-Day Session Gainers AeroCentury Corp. (NYSE: ACY) shares jumped 227.2% to $8.80 after the company reported that the NYSE accepted its plan for continued listing.
- benzinga.com 36 Stocks Moving in Thursday's Pre-Market Session Gainers Senseonics Holdings, Inc. (NYSE: SENS) shares rose 79.7% to $1.16 in pre-market trading after the company lifted its sales guidance for the fourth quarter. The company said it now expects Q4…